49 related articles for article (PubMed ID: 25037979)
1. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer.
Seneviratne S; Campbell I; Scott N; Shirley R; Peni T; Lawrenson R
Cancer Epidemiol; 2014 Oct; 38(5):638-44. PubMed ID: 25037979
[TBL] [Abstract][Full Text] [Related]
2. Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database.
Kim BH; Yun EH; Lee JH; Hong G; Park JY; Shim JH; Kim E; Kong HJ; Jung KW; Lim YS
J Liver Cancer; 2024 Mar; 24(1):57-61. PubMed ID: 38528809
[TBL] [Abstract][Full Text] [Related]
3. Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute?
Boyle L; Lawrenson R; Nosa V; Campbell I; Tin Tin S
Breast Cancer Res Treat; 2024 Jun; 205(3):641-653. PubMed ID: 38536575
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with completeness in documentation of diagnostic work-up and treatment in patients with breast cancer in Sudan.
Eltoum NI; Caston NE; Gutnik L; Alazm MAA; Mohamed FO; Abdalkarem LM; Ali SAS; Badawi AZ; Henderson NL; Azuero A; Rocque G
Ecancermedicalscience; 2023; 17():1632. PubMed ID: 38414946
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
Krüerke D; Schenker M; Matter-Walstra K
BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with diagnostic and pre-treatment intervals among breast cancer patients attending care at the Uganda Cancer Institute: A cross-sectional study.
Achan J; Kasujja FX; Opito R; Wabinga H; Orach CG; Mwaka AD
Cancer Med; 2023 Oct; 12(19):19701-19713. PubMed ID: 37787090
[TBL] [Abstract][Full Text] [Related]
7. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.
Scott OW; TinTin S; Harborg S; Kuper-Hommel MJJ; Lawrenson R; Elwood JM
Breast Cancer Res Treat; 2023 May; 199(1):195-206. PubMed ID: 36930345
[TBL] [Abstract][Full Text] [Related]
8. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
Scott OW; Tin Tin S; Elwood JM; Cavadino A; Habel LA; Kuper-Hommel M; Campbell I; Lawrenson R
Breast Cancer Res Treat; 2022 May; 193(1):225-235. PubMed ID: 35286523
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of breast cancer patients at dr. Sardjito Hospital for early anticipation of neutropenia: Cross-sectional study.
Fathoni MIA; Gunardi ; Adi-Kusumo F; Hutajulu SH; Purwanto I
Ann Med Surg (Lond); 2022 Jan; 73():103189. PubMed ID: 35079356
[TBL] [Abstract][Full Text] [Related]
10. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.
Abrahimi MS; Elwood M; Lawrenson R; Campbell I; Tin Tin S
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800387
[TBL] [Abstract][Full Text] [Related]
11. Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival.
Aye PS; Scott OW; Elwood JM; Sarfati D; Lawrenson R; Campbell ID; Kuper-Hommel M; Tin Tin S
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33138255
[TBL] [Abstract][Full Text] [Related]
12. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.
Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C
BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255
[TBL] [Abstract][Full Text] [Related]
13. Treatment and survival of Asian women diagnosed with breast cancer in New Zealand.
Lao C; Lawrenson R; Edwards M; Campbell I
Breast Cancer Res Treat; 2019 Sep; 177(2):497-505. PubMed ID: 31168758
[TBL] [Abstract][Full Text] [Related]
14. Data Reliability and Coding Completeness of Cancer Registry Information Using Reabstracting Method in the National Cancer Institute: Thailand, 2012 to 2014.
Sirirungreung A; Buasom R; Jiraphongsa C; Sangrajrang S
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241269
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.
Di Girolamo C; Walters S; Benitez Majano S; Rachet B; Coleman MP; Njagi EN; Morris M
BMC Cancer; 2018 May; 18(1):492. PubMed ID: 29716543
[TBL] [Abstract][Full Text] [Related]
17. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
[TBL] [Abstract][Full Text] [Related]
18. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?
Tin Tin S; Elwood JM; Brown C; Sarfati D; Campbell I; Scott N; Ramsaroop R; Seneviratne S; Harvey V; Lawrenson R
BMC Cancer; 2018 Jan; 18(1):58. PubMed ID: 29310606
[TBL] [Abstract][Full Text] [Related]
19. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand.
Seneviratne S; Campbell I; Scott N; Lawrenson R
BMC Health Serv Res; 2017 Jan; 17(1):64. PubMed ID: 28109301
[TBL] [Abstract][Full Text] [Related]
20. Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?
Tin Tin S; Elwood JM; Lawrenson R; Campbell I; Harvey V; Seneviratne S
PLoS One; 2016; 11(4):e0153206. PubMed ID: 27054698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
